LIVIVO - Search results -

Search results

Result 1 - 10 of total 32

Search options

Article ; Online: Fractional Er:YAG Laser and 0.01% Bimatoprost in Leucoderma From Iatrogenic Melasma Treatment in a Skin Phototype V Patient.

Eimpunth, Sasima / Pacharapakornpong, Sarun / Yogya, Yuri / Weiss, Margaret A

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.

2023 Volume 49, Issue 9, Page(s) 899–901

MeSH term(s)	Humans ; Bimatoprost/adverse effects ; Lasers, Solid-State/adverse effects ; Skin ; Treatment Outcome ; Hypopigmentation/chemically induced ; Melanosis/etiology ; Melanosis/therapy ; Iatrogenic Disease
Chemical Substances	Bimatoprost (QXS94885MZ)
Language	English
Publishing date	2023-06-29
Publishing country	United States
Document type	Journal Article
ZDB-ID	1227586-4
ISSN	1524-4725 ; 1076-0512
ISSN (online)	1524-4725
ISSN	1076-0512
DOI	10.1097/DSS.0000000000003868
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1212: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Book: Sclerotherapy and vein treatment

Weiss, Robert A. / Weiss, Margaret A. / Beasley, Karen L.

2012

Author's details	Robert A. Weiss ; Margaret A. Weiss ; Karen L. Beasley
Keywords	Varicose Veins / diagnosis ; Varicose Veins / therapy ; Sclerotherapy / methods
Language	English
Edition	2. ed.
Publisher	McGraw-Hill Med
Publishing place	New York u.a.
Publishing country	United States
Document type	Book
Note	Includes bibliographical references and index ; The spectrum of venous disease -- Venous anatomy -- Histology -- Venous physiology and pathology -- Common patterns of abnormal veins : guide and summary by region -- History and physical examination -- Common clinical presentations -- Continuous wave doppler -- Physiologic and other tests for venous evaluation -- Venous imaging/duplex ultrasound -- Patient education and informed consent -- Sclerotherapy of large varicose veins -- Sclerotherapy of small veins -- Sclerosing solutions -- Compression -- Veins at other sites -- Facial veins -- Special situations and problems -- Foam sclerotherapy -- Lasers and high-intensity pulsed light -- Endovenous laser ablation -- Ambulatory phlebectomy -- RF endovenous occlusion (closure or closurefast) -- Minimizing and treating complications -- Outfitting the phlebology practice
Accompanying material	1 DVD (12 cm)
Old title	1. Aufl. u.d.T. Vein diagnosis and treatment
HBZ-ID	HT017070111
ISBN	978-0-07-148542-5 ; 0-07-148542-2
Database	Catalogue ZB MED Medicine, Health

In stock of ZB MED Cologne/Königswinter

Shelf mark	Loan status	Location
2011 A 5478	order for loan	Magazin
2011 MO 744 <<[Begleitmaterial]>>	order for loan	Magazin

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Book: Vein diagnosis and treatment

Weiss, Robert A. / Feied, Craig / Weiss, Margaret A.

a comprehensive approach

2001

Title variant	Vein diagnosis & treatment
Author's details	Robert A. Weiss ; Craig Freied ; Margaret A. Weiss
Keywords	Varicose Veins / diagnosis ; Sclerotherapy / methods ; Varicose Veins / therapy
Language	English
Size	XV, 304 S. : Ill., graph. Darst.
Publisher	McGraw-Hill, Med. Publ. Division
Publishing place	New York u.a.
Publishing country	United States
Document type	Book
New title	2. Aufl. u.d.T Weiss, Robert A. : Sclerotherapy and vein treatment
HBZ-ID	HT012879411
ISBN	0-07-069201-7 ; 978-0-07-069201-5
Database	Catalogue ZB MED Medicine, Health

In stock of ZB MED Cologne/Königswinter

Shelf mark	Loan status	Location
2000 A 5621	order for loan	Magazin

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Evaluation of a novel anti-aging topical formulation containing cycloastragenol, growth factors, peptides, and antioxidants.

Weiss, Robert A / Weiss, Margaret A

Journal of drugs in dermatology : JDD

2014 Volume 13, Issue 9, Page(s) 1135–1139

Abstract: Background/objective: This study investigates the efficacy, tolerance, and usability of a single product containing cycloastragenol, growth factors, peptides, and antioxidants to decrease the visible signs of aging, including fine lines, and wrinkles, ... ...

Abstract	Background/objective: This study investigates the efficacy, tolerance, and usability of a single product containing cycloastragenol, growth factors, peptides, and antioxidants to decrease the visible signs of aging, including fine lines, and wrinkles, texture, pore size, elasticity, skin color/clarity, redness, hydration, and overall skin quality. Methods: Twenty subjects were enrolled in a 12-week, open-label, patient-assessment study. Subjects used a gentle cleanser, cycloastragenol, growth factors, peptides, and antioxidants (Regeneration Booster™, Jan Marini Skin Research (San Jose, CA) and a broad spectrum SPF for the duration of the 12-week study. Assessments were taken at baseline, 2, 4, 8, and 12 weeks. All assessments were compared against baseline for statistical significance. Results: Eighteen of the twenty subjects completed the 12-week study. Improvement was significant after just 2 weeks of use for all measured categories except erythema and significant for all categories at 12 weeks. One hundred percent of study subjects noted improvement in at least 3 or more of the 8 assessed categories with an average improvement in 6.7 categories. Improvement response rate for individual categories ranged from 67% to 100% of study subjects. There were zero cases of sensitivity or irritation and product smell, feel and ease of application were rated "positive" by 100% of study subjects. Photographic improvement was most notable in texture and lines on the cheeks and eye area. Conclusion: Regeneration Booster, when used as a stand-alone anti-aging solution, delivers rapid and significant reduction in the visible signs of aging. Subject satisfaction was extremely high and there were zero reported cases of sensitivity or irritation. Based on these observations, Regeneration Booster is a safe and effective topical product for individuals seeking significant improvement in the appearance of aging skin.
MeSH term(s)	Administration, Cutaneous ; Adult ; Aged ; Antioxidants/administration & dosage ; Chemistry, Pharmaceutical ; Drug Evaluation/methods ; Female ; Humans ; Intercellular Signaling Peptides and Proteins/administration & dosage ; Male ; Middle Aged ; Peptides/administration & dosage ; Sapogenins/administration & dosage ; Skin Aging/drug effects ; Skin Aging/pathology ; Skin Care/methods
Chemical Substances	Antioxidants ; Intercellular Signaling Peptides and Proteins ; Peptides ; Sapogenins ; cycloastragenol (X37D9F2L0V)
Language	English
Publishing date	2014-09
Publishing country	United States
Document type	Journal Article
ZDB-ID	2145090-0
ISSN	1545-9616
ISSN	1545-9616
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5931: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Safety of Combination Laser or Intense Pulsed Light Therapies and Doxycycline for the Treatment of Rosacea.

Schilling, Laura M / Halvorson, Christian R / Weiss, Robert A / Weiss, Margaret A / Beasley, Karen L

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.

2019 Volume 45, Issue 11, Page(s) 1401–1405

Abstract: Background: Current treatment options for rosacea include topical agents, oral therapies, phototherapy using lasers, or intense pulsed light (IPL). Combination therapy for rosacea often yields better results than monotherapy. The safety of laser/light ... ...

Abstract	Background: Current treatment options for rosacea include topical agents, oral therapies, phototherapy using lasers, or intense pulsed light (IPL). Combination therapy for rosacea often yields better results than monotherapy. The safety of laser/light treatments in combination with systemic doxycycline has been questioned because of the theoretical risk of photosensitivity. Objective: The purpose of this study was to assess the incidence of phototoxicity or photosensitivity in rosacea patients receiving concomitant laser or light treatments and systemic doxycycline. Methods: Treatment records of 36 patients receiving laser/light treatments while also being treated with standard dose or anti-inflammatory dose of doxycycline were retrospectively reviewed. Results: No adverse reactions related to doxycycline combined with laser/light therapy were reported. Specifically, no photosensitivity or sensitivity to wavelengths in the pulsed dye laser (PDL), or IPL range was observed in this cohort. All patients achieved some degree of clearance. Conclusion: The results of this retrospective study demonstrate that doxycycline used in conjunction with laser or nonlaser light therapy is a valid combination therapy for improving signs and symptoms of rosacea. No photosensitivity reactions were observed to commonly used IPL or PDL devices.
MeSH term(s)	Administration, Cutaneous ; Adolescent ; Adult ; Aged ; Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/adverse effects ; Combined Modality Therapy/adverse effects ; Combined Modality Therapy/methods ; Delayed-Action Preparations/administration & dosage ; Delayed-Action Preparations/adverse effects ; Doxycycline/administration & dosage ; Doxycycline/adverse effects ; Female ; Humans ; Intense Pulsed Light Therapy/adverse effects ; Intense Pulsed Light Therapy/instrumentation ; Intense Pulsed Light Therapy/methods ; Lasers, Dye/adverse effects ; Low-Level Light Therapy/adverse effects ; Low-Level Light Therapy/methods ; Male ; Middle Aged ; Photosensitivity Disorders/diagnosis ; Photosensitivity Disorders/etiology ; Retrospective Studies ; Rosacea/therapy ; Skin/drug effects ; Skin/radiation effects ; Treatment Outcome ; Young Adult
Chemical Substances	Anti-Bacterial Agents ; Delayed-Action Preparations ; Doxycycline (N12000U13O)
Language	English
Publishing date	2019-10-28
Publishing country	United States
Document type	Journal Article
ZDB-ID	1227586-4
ISSN	1524-4725 ; 1076-0512
ISSN (online)	1524-4725
ISSN	1076-0512
DOI	10.1097/DSS.0000000000002009
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1212: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Adding sclerotherapy to your practice.

Weiss, Margaret A / Weiss, Robert A

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.

2010 Volume 36 Suppl 2, Page(s) 1034–1039

MeSH term(s)	Current Procedural Terminology ; Documentation ; Humans ; Medical Records ; Patient Education as Topic ; Photography ; Practice Management, Medical/organization & administration ; Sclerosing Solutions ; Sclerotherapy/instrumentation ; Telangiectasis/diagnostic imaging ; Telangiectasis/therapy ; Ultrasonography
Chemical Substances	Sclerosing Solutions
Language	English
Publishing date	2010-06
Publishing country	United States
Document type	Journal Article
ZDB-ID	1227586-4
ISSN	1524-4725 ; 1076-0512
ISSN (online)	1524-4725
ISSN	1076-0512
DOI	10.1111/j.1524-4725.2010.01497.x
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1212: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Comparative outcomes of different endovenous thermal ablation systems on great and small saphenous vein insufficiency: Long-term results.

Weiss, Robert A / Weiss, Margaret A / Eimpunth, Sasima / Wheeler, Sandra / Udompunturak, Suthipol / Beasley, Karen L

Lasers in surgery and medicine

2015 Volume 47, Issue 2, Page(s) 156–160

Abstract: Background and objective: This study examined the outcomes of over a decade of endovenous thermal ablation (EVTA) treatments for great and small saphenous vein (GSV and SSV) insufficiency, utilizing three different endovenous thermal ablation systems.!## ...

Abstract	Background and objective: This study examined the outcomes of over a decade of endovenous thermal ablation (EVTA) treatments for great and small saphenous vein (GSV and SSV) insufficiency, utilizing three different endovenous thermal ablation systems. Materials and methods: This retrospective study reviewed EVTA treatments performed at an outpatient clinic (MDLSVI) from April 1999 to February 2013. Systems included 810 nm diode (hemoglobin targeting), 1,320 nm laser (water targeting) and a radiofrequency (direct thermal transfer) (RF) device. Clinical and ultrasonographic evaluation were performed before treatment and at each follow-up visit. Patients were examined yearly by Duplex ultrasonography. Success was defined as complete absence of reflux. Results: Analysis of 934 treatments demonstrated that although recanalization could occur over time, endovenous ablation has a very high success rate. Ablation rates were 92.5%, 85.9%, and 71.9% at 6-months, 1-year, and 5-years after procedures. Recanalization occurred in 156 out of 934 treatments (16.7%) during the follow-up period. Among three difference systems, the total ablation success rate was significantly different (P < 0.001). The 1,320 nm Nd:YAG laser (n = 502) provided the highest ablation rate compared to the radiofrequency (n = 398) and 810 nm diode (n = 34) throughout their follow-up period, which were 8, 13, and 9 years, respectively. At 1-year follow-up, successful ablation rates of RF, 810 nm, and 1,320 nm were 78.2%, 80.8%, and 93.7%, respectively. At 5-year follow-up, successful ablation rates of RF, 810 nm, and 1,320 nm were 61.7%, 65.7%, and 84.7%, respectively. Conclusion: EVTA is very effective for ablation of the GSV and SSV. Complete ablation varied significantly among different systems with water targeting 1,320 nm providing the highest incidence saphenous vein ablation. This remained durable at 8-year follow-up by Duplex ultrasound.
MeSH term(s)	Adolescent ; Adult ; Aged ; Aged, 80 and over ; Catheter Ablation/instrumentation ; Female ; Follow-Up Studies ; Humans ; Laser Therapy/instrumentation ; Male ; Middle Aged ; Retrospective Studies ; Saphenous Vein ; Survival Analysis ; Time Factors ; Treatment Outcome ; Venous Insufficiency/diagnosis ; Venous Insufficiency/therapy ; Young Adult
Keywords	covid19
Language	English
Publishing date	2015-02
Publishing country	United States
Document type	Clinical Study ; Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	604493-1
ISSN	1096-9101 ; 0196-8092
ISSN (online)	1096-9101
ISSN	0196-8092
DOI	10.1002/lsm.22335
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1603: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Soft tissue augmentation using a two-way connector to supplement hyaluronic acid filler with 1% lidocaine hydrochloric acid with epinephrine 1:100,000: our experience and observations.

Beasley, Karen L / Weiss, Margaret A / Weiss, Robert A

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.

2010 Volume 36, Issue 4, Page(s) 524–526

MeSH term(s)	Anesthesia, Local/methods ; Anesthetics, Local/administration & dosage ; Cosmetic Techniques ; Epinephrine/administration & dosage ; Humans ; Hyaluronic Acid/administration & dosage ; Injections, Intradermal ; Injections, Subcutaneous ; Lidocaine/administration & dosage ; Patient Satisfaction ; Reconstructive Surgical Procedures/methods
Chemical Substances	Anesthetics, Local ; Hyaluronic Acid (9004-61-9) ; Lidocaine (98PI200987) ; Epinephrine (YKH834O4BH)
Language	English
Publishing date	2010-04
Publishing country	United States
Document type	Journal Article
ZDB-ID	1227586-4
ISSN	1524-4725 ; 1076-0512
ISSN (online)	1524-4725
ISSN	1076-0512
DOI	10.1111/j.1524-4725.2010.01488.x
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1212: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Safety and efficacy of a novel diffractive lens array using a picosecond 755 nm alexandrite laser for treatment of wrinkles.

Weiss, Robert A / McDaniel, David H / Weiss, Margaret A / Mahoney, Anne Marie / Beasley, Karen L / Halvorson, Christian R

Lasers in surgery and medicine

2017 Volume 49, Issue 1, Page(s) 40–44

Abstract: Introduction: Picosecond lasers have been reported to be effective for removal of tattoo pigment. This prospective study evaluated the efficacy and safety of the treatment of peri-oral and -ocular wrinkles using a novel diffractive lens array coupled ... ...

Abstract	Introduction: Picosecond lasers have been reported to be effective for removal of tattoo pigment. This prospective study evaluated the efficacy and safety of the treatment of peri-oral and -ocular wrinkles using a novel diffractive lens array coupled with a picosecond 755 nm alexandrite laser. Methods: Forty female subjects presenting with wrinkles from photodamage were enrolled in an IRB approved study. Subjects received four picosecond diffractive lens array treatments to the full face at 1 month intervals. Six subjects were biopsied (two subjects at 1 month, two subjects at 3 months, and two subjects at 6 months). Digital photographic images were taken at 1, 3, and 6 months post-final treatment visits. Images were graded by blinded physicians for fine lines/wrinkles, erythema, dyschromia, and global improvement. Data on discomfort level, satisfaction, and side effects were recorded. Results: Overall blinded physician rated global improvement ranged from improved to much improved at 1-, 3-, and 6-month time points. At baseline the average Fitzpatrick wrinkle score was 5.48. At the 6-month follow-up the average score was 3.47. The overall average change in score from pre-treatment to post-treatment was 1.97. Subject self-assessment at 6 months indicated that 90% of subjects were extremely or satisfied with their results. Unanticipated adverse events were absent with anticipated post-treatment erythema lasting for just several hours. Conclusions: A novel diffractive lens array used with a picosecond 755 nm alexandrite laser for treatment of wrinkles is highly effective and safe for wrinkles and other signs of photoaging. Lasers Surg. Med. 49:40-44, 2017. © 2016 The Authors. Lasers in Surgery and Medicine Published by Wiley Periodicals, Inc.
MeSH term(s)	Adult ; Esthetics ; Female ; Humans ; Lasers, Solid-State/therapeutic use ; Low-Level Light Therapy/methods ; Middle Aged ; Patient Satisfaction ; Prospective Studies ; Rejuvenation ; Risk Assessment ; Single-Blind Method ; Skin Aging/radiation effects ; Treatment Outcome
Language	English
Publishing date	2017
Publishing country	United States
Document type	Clinical Trial ; Journal Article
ZDB-ID	604493-1
ISSN	1096-9101 ; 0196-8092
ISSN (online)	1096-9101
ISSN	0196-8092
DOI	10.1002/lsm.22577
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1603: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Hyaluronic acid fillers: a comprehensive review.

Beasley, Karen L / Weiss, Margaret A / Weiss, Robert A

Facial plastic surgery : FPS

2009 Volume 25, Issue 2, Page(s) 86–94

Abstract: Over the past decade, the popularity of nonsurgical cosmetic procedures has increased exponentially. Last year, according to the American Society of Aesthetic Plastic Surgery, more than 5 million procedures were performed using cosmetic injectables such ... ...

Abstract	Over the past decade, the popularity of nonsurgical cosmetic procedures has increased exponentially. Last year, according to the American Society of Aesthetic Plastic Surgery, more than 5 million procedures were performed using cosmetic injectables such as botulinum toxin and dermal filling agents. According to the society's recent statistics, more than 85% of all dermal filler procedures occurred with a hyaluronic acid derivative.These numbers are expected to rise in the future as there is currently no other class of filling agent that rivals the popularity of hyaluronic acid. The popularity of hyaluronic acid specifically stems from its effectiveness, ease of administration, and safety profile.
MeSH term(s)	Biocompatible Materials/administration & dosage ; Biocompatible Materials/adverse effects ; Biocompatible Materials/chemistry ; Cosmetic Techniques ; Cross-Linking Reagents ; Face ; Humans ; Hyaluronic Acid/administration & dosage ; Hyaluronic Acid/adverse effects ; Hyaluronic Acid/chemistry ; Injections ; Molecular Structure ; Rejuvenation ; Skin Aging
Chemical Substances	Biocompatible Materials ; Cross-Linking Reagents ; Hyaluronic Acid (9004-61-9)
Language	English
Publishing date	2009-05
Publishing country	United States
Document type	Journal Article ; Review
ZDB-ID	630090-x
ISSN	1098-8793 ; 0736-6825
ISSN (online)	1098-8793
ISSN	0736-6825
DOI	10.1055/s-0029-1220647
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Se 898: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito